annual FCF:
$10.39B+$3.04B(+41.24%)Summary
- As of today (April 16, 2025), AMGN annual free cash flow is $10.39 billion, with the most recent change of +$3.04 billion (+41.24%) on December 31, 2024.
- During the last 3 years, AMGN annual FCF has risen by +$2.01 billion (+24.02%).
- AMGN annual FCF is now -1.55% below its all-time high of $10.56 billion, reached on December 31, 2018.
Performance
AMGN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$4.40B+$1.09B(+32.77%)Summary
- As of today (April 16, 2025), AMGN quarterly free cash flow is $4.40 billion, with the most recent change of +$1.09 billion (+32.77%) on December 31, 2024.
- Over the past year, AMGN quarterly FCF has increased by +$4.11 billion (+1422.49%).
- AMGN quarterly FCF is now at all-time high.
Performance
AMGN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$10.39B+$4.11B(+65.43%)Summary
- As of today (April 16, 2025), AMGN TTM free cash flow is $10.39 billion, with the most recent change of +$4.11 billion (+65.43%) on December 31, 2024.
- Over the past year, AMGN TTM FCF has increased by +$3.04 billion (+41.24%).
- AMGN TTM FCF is now -4.36% below its all-time high of $10.87 billion, reached on March 31, 2018.
Performance
AMGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AMGN Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +41.2% | +1422.5% | +41.2% |
3 y3 years | +24.0% | +74.5% | +24.0% |
5 y5 years | +21.8% | +89.2% | +18.2% |
AMGN Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +41.2% | at high | +1422.5% | at high | +89.6% |
5 y | 5-year | at high | +41.2% | at high | +1422.5% | at high | +89.6% |
alltime | all time | -1.6% | >+9999.0% | at high | +6127.4% | -4.4% | >+9999.0% |
Amgen Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $10.39B(+41.2%) | $4.40B(+32.8%) | $10.39B(+65.4%) |
Sep 2024 | - | $3.31B(+49.2%) | $6.28B(+14.6%) |
Jun 2024 | - | $2.22B(+383.9%) | $5.48B(-22.8%) |
Mar 2024 | - | $459.00M(+58.8%) | $7.10B(-3.5%) |
Dec 2023 | $7.36B(-16.2%) | $289.00M(-88.5%) | $7.36B(-21.5%) |
Sep 2023 | - | $2.51B(-34.5%) | $9.38B(-3.2%) |
Jun 2023 | - | $3.84B(+433.1%) | $9.69B(+28.6%) |
Mar 2023 | - | $720.00M(-68.8%) | $7.53B(-14.3%) |
Dec 2022 | $8.79B(+4.8%) | $2.31B(-18.1%) | $8.79B(-2.4%) |
Sep 2022 | - | $2.82B(+67.3%) | $9.00B(+7.7%) |
Jun 2022 | - | $1.68B(-14.7%) | $8.36B(-0.7%) |
Mar 2022 | - | $1.97B(-21.7%) | $8.42B(+0.4%) |
Dec 2021 | $8.38B(-15.2%) | $2.52B(+15.9%) | $8.38B(+6.9%) |
Sep 2021 | - | $2.18B(+24.6%) | $7.84B(-11.9%) |
Jun 2021 | - | $1.75B(-9.9%) | $8.90B(-9.5%) |
Mar 2021 | - | $1.94B(-2.1%) | $9.84B(-0.5%) |
Dec 2020 | $9.89B(+15.9%) | $1.98B(-38.8%) | $9.89B(-3.4%) |
Sep 2020 | - | $3.23B(+20.5%) | $10.23B(+0.3%) |
Jun 2020 | - | $2.68B(+34.7%) | $10.21B(+16.1%) |
Mar 2020 | - | $1.99B(-14.4%) | $8.79B(+3.1%) |
Dec 2019 | $8.53B(-19.2%) | $2.33B(-27.5%) | $8.53B(-7.0%) |
Sep 2019 | - | $3.21B(+152.5%) | $9.18B(+1.2%) |
Jun 2019 | - | $1.27B(-26.5%) | $9.07B(-6.6%) |
Mar 2019 | - | $1.73B(-41.8%) | $9.71B(-8.0%) |
Dec 2018 | $10.56B(+0.4%) | $2.97B(-4.3%) | $10.56B(+1.1%) |
Sep 2018 | - | $3.10B(+62.0%) | $10.45B(-1.8%) |
Jun 2018 | - | $1.92B(-25.5%) | $10.64B(-2.1%) |
Mar 2018 | - | $2.57B(-10.0%) | $10.87B(+3.4%) |
Dec 2017 | $10.51B(+9.3%) | $2.86B(-13.3%) | $10.51B(-0.1%) |
Sep 2017 | - | $3.30B(+53.9%) | $10.53B(+7.1%) |
Jun 2017 | - | $2.14B(-3.4%) | $9.82B(-2.5%) |
Mar 2017 | - | $2.22B(-22.8%) | $10.07B(+4.8%) |
Dec 2016 | $9.62B(+5.2%) | $2.87B(+10.8%) | $9.62B(+11.7%) |
Sep 2016 | - | $2.59B(+8.5%) | $8.61B(-2.4%) |
Jun 2016 | - | $2.39B(+35.9%) | $8.82B(-7.5%) |
Mar 2016 | - | $1.76B(-5.8%) | $9.53B(+4.3%) |
Dec 2015 | $9.14B(+14.9%) | $1.87B(-33.4%) | $9.14B(-6.5%) |
Sep 2015 | - | $2.80B(-9.6%) | $9.77B(+4.1%) |
Jun 2015 | - | $3.10B(+127.3%) | $9.39B(+12.5%) |
Mar 2015 | - | $1.36B(-45.5%) | $8.34B(+5.0%) |
Dec 2014 | $7.95B(+42.0%) | $2.50B(+3.4%) | $7.95B(+12.3%) |
Sep 2014 | - | $2.42B(+17.9%) | $7.08B(+12.5%) |
Jun 2014 | - | $2.05B(+111.8%) | $6.29B(+10.8%) |
Mar 2014 | - | $970.00M(-40.6%) | $5.68B(+1.4%) |
Dec 2013 | $5.60B(+8.3%) | $1.63B(+0.1%) | $5.60B(+23.0%) |
Sep 2013 | - | $1.63B(+13.3%) | $4.55B(+1.8%) |
Jun 2013 | - | $1.44B(+61.7%) | $4.47B(-14.6%) |
Mar 2013 | - | $891.00M(+51.8%) | $5.23B(+1.2%) |
Dec 2012 | $5.17B(+13.5%) | $587.00M(-62.1%) | $5.17B(-13.0%) |
Sep 2012 | - | $1.55B(-29.6%) | $5.94B(+13.4%) |
Jun 2012 | - | $2.20B(+166.1%) | $5.24B(+17.8%) |
Mar 2012 | - | $828.00M(-39.1%) | $4.45B(-2.2%) |
Dec 2011 | $4.55B(-12.6%) | $1.36B(+60.2%) | $4.55B(-9.3%) |
Sep 2011 | - | $849.00M(-39.9%) | $5.02B(-6.1%) |
Jun 2011 | - | $1.41B(+51.9%) | $5.34B(+0.5%) |
Mar 2011 | - | $930.00M(-49.1%) | $5.32B(+2.1%) |
Dec 2010 | $5.21B(-10.3%) | $1.83B(+55.4%) | $5.21B(+2.9%) |
Sep 2010 | - | $1.18B(-15.3%) | $5.06B(-11.7%) |
Jun 2010 | - | $1.39B(+69.4%) | $5.73B(-2.6%) |
Mar 2010 | - | $819.00M(-51.2%) | $5.88B(+1.3%) |
Dec 2009 | $5.81B(+9.2%) | $1.68B(-9.0%) | $5.81B(+8.6%) |
Sep 2009 | - | $1.84B(+19.8%) | $5.35B(+13.0%) |
Jun 2009 | - | $1.54B(+107.5%) | $4.73B(+1.9%) |
Mar 2009 | - | $742.00M(-39.1%) | $4.65B(-12.6%) |
Dec 2008 | $5.32B(+28.6%) | $1.22B(-1.0%) | $5.32B(-1.4%) |
Sep 2008 | - | $1.23B(-15.3%) | $5.39B(-0.9%) |
Jun 2008 | - | $1.45B(+3.0%) | $5.44B(+9.4%) |
Mar 2008 | - | $1.41B(+9.0%) | $4.98B(+20.4%) |
Dec 2007 | $4.13B | $1.30B(+1.1%) | $4.13B(+11.9%) |
Sep 2007 | - | $1.28B(+29.8%) | $3.70B(+2.4%) |
Jun 2007 | - | $988.00M(+73.9%) | $3.61B(-4.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $568.00M(-33.8%) | $3.78B(-9.4%) |
Dec 2006 | $4.17B(+3.1%) | $858.00M(-28.3%) | $4.17B(-0.1%) |
Sep 2006 | - | $1.20B(+3.4%) | $4.18B(-1.1%) |
Jun 2006 | - | $1.16B(+20.9%) | $4.22B(+3.6%) |
Mar 2006 | - | $958.00M(+10.9%) | $4.08B(+0.8%) |
Dec 2005 | $4.04B(+71.3%) | $864.00M(-30.5%) | $4.04B(+1.3%) |
Sep 2005 | - | $1.24B(+22.8%) | $3.99B(+13.3%) |
Jun 2005 | - | $1.01B(+9.4%) | $3.53B(+7.7%) |
Mar 2005 | - | $925.00M(+13.6%) | $3.27B(+38.6%) |
Dec 2004 | $2.36B(+6.8%) | $814.00M(+5.0%) | $2.36B(+1.8%) |
Sep 2004 | - | $775.00M(+2.1%) | $2.32B(+28.5%) |
Jun 2004 | - | $759.00M(+5738.5%) | $1.81B(+5.6%) |
Mar 2004 | - | $13.00M(-98.3%) | $1.71B(-22.6%) |
Dec 2003 | $2.21B(+39.0%) | $773.00M(+196.7%) | $2.21B(+10.5%) |
Sep 2003 | - | $260.50M(-60.8%) | $2.00B(+9.0%) |
Jun 2003 | - | $663.90M(+29.5%) | $1.83B(+8.1%) |
Mar 2003 | - | $512.60M(-9.0%) | $1.70B(+6.8%) |
Dec 2002 | $1.59B(+53.1%) | $563.20M(+494.1%) | $1.59B(+11.9%) |
Sep 2002 | - | $94.80M(-82.0%) | $1.42B(-5.5%) |
Jun 2002 | - | $527.10M(+30.2%) | $1.50B(+23.8%) |
Mar 2002 | - | $404.90M(+2.7%) | $1.21B(+17.0%) |
Dec 2001 | $1.04B(-13.2%) | $394.20M(+121.8%) | $1.04B(+15.9%) |
Sep 2001 | - | $177.70M(-25.3%) | $896.20M(-25.1%) |
Jun 2001 | - | $238.00M(+4.2%) | $1.20B(-2.3%) |
Mar 2001 | - | $228.50M(-9.3%) | $1.22B(+2.2%) |
Dec 2000 | $1.20B(+55.2%) | $252.00M(-47.2%) | $1.20B(+14.7%) |
Sep 2000 | - | $477.30M(+79.6%) | $1.04B(+27.1%) |
Jun 2000 | - | $265.80M(+31.7%) | $820.60M(-3.3%) |
Mar 2000 | - | $201.80M(+105.1%) | $848.50M(+10.0%) |
Dec 1999 | $771.10M(+21.7%) | $98.40M(-61.4%) | $771.10M(-10.8%) |
Sep 1999 | - | $254.60M(-13.3%) | $864.90M(+11.9%) |
Jun 1999 | - | $293.70M(+136.1%) | $772.80M(+30.4%) |
Mar 1999 | - | $124.40M(-35.3%) | $592.70M(-6.5%) |
Dec 1998 | $633.70M(+23.0%) | $192.20M(+18.3%) | $633.70M(+8.7%) |
Sep 1998 | - | $162.50M(+43.0%) | $583.00M(+12.3%) |
Jun 1998 | - | $113.60M(-31.3%) | $519.20M(-5.8%) |
Mar 1998 | - | $165.40M(+16.9%) | $550.90M(+7.0%) |
Dec 1997 | $515.10M(-7.3%) | $141.50M(+43.4%) | $515.10M(-6.5%) |
Sep 1997 | - | $98.70M(-32.1%) | $551.10M(+4.4%) |
Jun 1997 | - | $145.30M(+12.1%) | $528.00M(-16.8%) |
Mar 1997 | - | $129.60M(-27.0%) | $634.50M(+14.2%) |
Dec 1996 | $555.70M(-9.0%) | $177.50M(+134.8%) | $555.70M(+1.5%) |
Sep 1996 | - | $75.60M(-70.0%) | $547.30M(-10.2%) |
Jun 1996 | - | $251.80M(+395.7%) | $609.50M(+15.0%) |
Mar 1996 | - | $50.80M(-70.0%) | $530.00M(-13.2%) |
Dec 1995 | $610.50M(+52.2%) | $169.10M(+22.7%) | $610.50M(+3.8%) |
Sep 1995 | - | $137.80M(-20.0%) | $588.40M(+6.4%) |
Jun 1995 | - | $172.30M(+31.2%) | $552.90M(+22.1%) |
Mar 1995 | - | $131.30M(-10.7%) | $452.70M(+12.9%) |
Dec 1994 | $401.10M(+79.8%) | $147.00M(+43.7%) | $401.10M(+0.8%) |
Sep 1994 | - | $102.30M(+41.9%) | $397.80M(-0.9%) |
Jun 1994 | - | $72.10M(-9.5%) | $401.30M(+6.8%) |
Mar 1994 | - | $79.70M(-44.5%) | $375.80M(+68.4%) |
Dec 1993 | $223.10M(+205.6%) | $143.70M(+35.8%) | $223.10M(+121.8%) |
Sep 1993 | - | $105.80M(+127.0%) | $100.60M(+1664.9%) |
Jun 1993 | - | $46.60M(-163.8%) | $5.70M(-141.6%) |
Mar 1993 | - | -$73.00M(-444.3%) | -$13.70M(-118.8%) |
Dec 1992 | $73.00M(-28.7%) | $21.20M(+94.5%) | $73.00M(+40.9%) |
Sep 1992 | - | $10.90M(-59.9%) | $51.80M(+26.7%) |
Jun 1992 | - | $27.20M(+98.5%) | $40.90M(+198.5%) |
Mar 1992 | - | $13.70M(-141.1%) | $13.70M(-126.7%) |
Dec 1991 | $102.40M(-299.2%) | - | - |
Mar 1991 | - | -$33.30M(-27.0%) | -$51.40M(+715.9%) |
Mar 1991 | -$51.40M(+102.4%) | - | - |
Dec 1990 | - | -$45.60M(+744.4%) | -$6.30M(-117.3%) |
Sep 1990 | - | -$5.40M(-116.4%) | $36.40M(+118.0%) |
Jun 1990 | - | $32.90M(+178.8%) | $16.70M(-165.7%) |
Mar 1990 | -$25.40M(-48.3%) | $11.80M(-506.9%) | -$25.40M(-31.7%) |
Dec 1989 | - | -$2.90M(-88.4%) | -$37.20M(+8.5%) |
Sep 1989 | - | -$25.10M(+172.8%) | -$34.30M(+272.8%) |
Jun 1989 | - | -$9.20M | -$9.20M |
Mar 1989 | -$49.10M | - | - |
FAQ
- What is Amgen annual free cash flow?
- What is the all time high annual FCF for Amgen?
- What is Amgen annual FCF year-on-year change?
- What is Amgen quarterly free cash flow?
- What is the all time high quarterly FCF for Amgen?
- What is Amgen quarterly FCF year-on-year change?
- What is Amgen TTM free cash flow?
- What is the all time high TTM FCF for Amgen?
- What is Amgen TTM FCF year-on-year change?
What is Amgen annual free cash flow?
The current annual FCF of AMGN is $10.39B
What is the all time high annual FCF for Amgen?
Amgen all-time high annual free cash flow is $10.56B
What is Amgen annual FCF year-on-year change?
Over the past year, AMGN annual free cash flow has changed by +$3.04B (+41.24%)
What is Amgen quarterly free cash flow?
The current quarterly FCF of AMGN is $4.40B
What is the all time high quarterly FCF for Amgen?
Amgen all-time high quarterly free cash flow is $4.40B
What is Amgen quarterly FCF year-on-year change?
Over the past year, AMGN quarterly free cash flow has changed by +$4.11B (+1422.49%)
What is Amgen TTM free cash flow?
The current TTM FCF of AMGN is $10.39B
What is the all time high TTM FCF for Amgen?
Amgen all-time high TTM free cash flow is $10.87B
What is Amgen TTM FCF year-on-year change?
Over the past year, AMGN TTM free cash flow has changed by +$3.04B (+41.24%)